Park HB - Search Results

1

Porcine PD-L1: cloning, characterization, and implications during xenotransplantation.

Jeon DH, Oh K, Oh BC, Nam DH, Kim CH, Park HB, Cho J, Lee JR, Lee DS, Lee G. Jeon DH, et al. Among authors: park hb. Xenotransplantation. 2007 May;14(3):236-42. doi: 10.1111/j.1399-3089.2007.00403.x. Xenotransplantation. 2007. PMID: 17489864

2

CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-γ pathway.

Park HB, Oh K, Garmaa N, Seo MW, Byoun OJ, Lee HY, Lee DS. Park HB, et al. Transplantation. 2010 Oct 27;90(8):825-35. doi: 10.1097/TP.0b013e3181f24e59. Transplantation. 2010. PMID: 20697326

3

Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.

Oh K, Park HB, Seo MW, Byoun OJ, Lee DS. Oh K, et al. Among authors: park hb. Clin Immunol. 2012 Nov;145(2):122-32. doi: 10.1016/j.clim.2012.08.009. Epub 2012 Aug 23. Clin Immunol. 2012. PMID: 23001131

4

Role of NKT cells in allogeneic islet graft survival.

Yang SH, Jin JZ, Lee SH, Park H, Kim CH, Lee DS, Kim S, Chung NH, Kim YS. Yang SH, et al. Clin Immunol. 2007 Sep;124(3):258-66. doi: 10.1016/j.clim.2007.06.003. Epub 2007 Jul 26. Clin Immunol. 2007. PMID: 17662658

5

Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice.

Oh K, Park HB, Byoun OJ, Shin DM, Jeong EM, Kim YW, Kim YS, Melino G, Kim IG, Lee DS. Oh K, et al. Among authors: park hb. J Exp Med. 2011 Aug 1;208(8):1707-19. doi: 10.1084/jem.20101457. Epub 2011 Jul 11. J Exp Med. 2011. PMID: 21746810 Free PMC article.

6

Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.

Park HB, Paik DJ, Jang E, Hong S, Youn J. Park HB, et al. Int Immunol. 2004 Aug;16(8):1203-13. doi: 10.1093/intimm/dxh123. Epub 2004 Jul 5. Int Immunol. 2004. PMID: 15237111

7

CTLA4-CD28 chimera gene modification of T cells enhances the therapeutic efficacy of donor lymphocyte infusion for hematological malignancy.

Park HB, Lee JE, Oh YM, Lee SJ, Eom HS, Choi K. Park HB, et al. Exp Mol Med. 2017 Jul 28;49(7):e360. doi: 10.1038/emm.2017.104. Exp Mol Med. 2017. PMID: 28751785 Free PMC article.

8

Adenovirus expressing both thymidine kinase and soluble PD1 enhances antitumor immunity by strengthening CD8 T-cell response.

Shin SP, Seo HH, Shin JH, Park HB, Lim DP, Eom HS, Bae YS, Kim IH, Choi K, Lee SJ. Shin SP, et al. Among authors: park hb. Mol Ther. 2013 Mar;21(3):688-95. doi: 10.1038/mt.2012.252. Epub 2013 Jan 22. Mol Ther. 2013. PMID: 23337984 Free PMC article.

9

Enhanced Anti-tumor Reactivity of Cytotoxic T Lymphocytes Expressing PD-1 Decoy.

Shin JH, Park HB, Choi K. Shin JH, et al. Among authors: park hb. Immune Netw. 2016 Apr;16(2):134-9. doi: 10.4110/in.2016.16.2.134. Epub 2016 Apr 28. Immune Netw. 2016. PMID: 27162530 Free PMC article.

10

Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus.

Park HB, Kim KC, Park JH, Kang TY, Lee HS, Kim TH, Jun JB, Bae SC, Yoo DH, Craft J, Jung S. Park HB, et al. Among authors: park jh. J Rheumatol. 2004 Nov;31(11):2151-5. J Rheumatol. 2004. PMID: 15517626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters